Europeans and Americans Share Concerns About Iran's Nuclear Program

Report Read time:
Europeans and Americans Share Concerns About Iran's Nuclear Program

As international pressure mounts on Iran to halt its nuclear program, Americans and Europeans generally express serious concerns about the potential threat from a nuclear-armed Iran. However, these fears are somewhat muted in Russia -- a nation that will be crucial to any effort to impose new sanctions on Iran.

A 14-nation survey by the Pew Research Center's Global Attitudes Project, conducted Aug. 27 through Sept. 24, finds worries about Iran developing nuclear weapons most common among Americans: 82% say that this would be a major threat to the well-being of the U.S. Similarly, concerns are widespread in Western Europe – large majorities in Spain (81%), Germany (79%), Italy (78%) and France (74%) view Iran's emergent nuclear capabilities as a major threat.

This view is less common among Eastern Europeans. Still, 69% of Czechs view Iran's potential nuclear capabilities as a threat, as do more than six-in-ten in Poland (65%), Bulgaria (63%) and Lithuania (62%). Roughly half in Slovakia (52%) and Hungary (46%) express worry about Iran developing a nuclear capacity.

By contrast, there is less concern about this issue in Russia, which, as a permanent member of the United Nations Security Council, has veto power over any UN effort to impose sanctions on Iran. Just over four-in-ten Russians (41%) say Iran's potential nuclear status poses a major threat to their country, while 48% deem it only a minor threat or not a threat at all. Ukrainians are even less worried – only 27% say Iran's emergent nuclear status is a major threat to their country, while nearly half (48%) say it is a minor danger or no danger at all. Many in Ukraine say they don't know (26%).

Read the full commentary Europeans and Americans Share Concerns About Iran's Nuclear Program on the Pew Research Center's Web site.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up

MORE FROM PEW

A pair of white and black Adélie penguins standing in the middle of a clump of snow face opposite directions. Seeing Antarctic Change, Scientist Calls for Stronger Action
A shipyard with towers in the foreground, a barge on a river, and a blue sky in the background. Louisiana Primed to Take Helm of Offshore Wind Supply Chain
About a dozen people stand examining large blue bins full of whole fish in a warehouse. Some people are in green clothes, others in blue, and all wear ballcaps. A few hold clipboards. Reducing Risk Strengthens the Seafood Supply Chain
A worker in a seafood market dumps bright orange shrimp from a blue bin onto a bed of ice between a lot of other seafood laid out for sale. Other workers are visible in the background, as are the arms of shoppers placing orders from the other side of the ice bed. Seafood Industry Benefits From Greater Vessel Transparency
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics
Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.
Quick View
Pills illustration

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.